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Heart performance declines with age. A likely contributor to age-associated car-
diac dysfunction is reduced protein quality control due to decreased function of
the ubiquitin/proteasome system (UPS) and the autophagy lysosomal pathway
(ALP). The transcription factor, FOXO, has been shown to be involved in the
regulation of genes related to both of these interrelated pathways as well as a
host of other cellular processes. Here, we investigated the effects of cardiac-
restricted overexpression of dFOXO in Drosophila melanogaster, an ideal
model for aging studies, exploiting the tissue-specific UAS-GAL4 expression
system. Using high-speed video microscopy and motion analysis and atomic
force microscopy, we showed that with age, mild heart-specific overexpression
of dFOXO significantly attenuated senescence-associated cardiac functional
decline and stiffening, respectively. We also determined that differing amounts
of heart-specific dFOXO overexpression elicited disparate effects, the strongest
driver proving fatal. Overexpression of dFOXO in all Drosophila muscle has
been shown to increase lifespan, likely owing to systemic expression of auto-
phagy related proteins and reduced ubiquitin content. Similarly, we found that
dFOXO-mediated improvement in heart function with age was also accompa-
nied by a significant decrease in ubiquitinated myocardial proteins as deter-
mined by quantitative western blot analysis. However, microarray data
suggested that this reduction was caused by increased expression of genes asso-
ciated with the UPS rather than autophagy, indicating that FOXO may perform
its function differently in the heart than in other striated muscles. Because
FOXO transcriptionally regulates genes associated with many facets of cellular
life, we have established a list of specific targets that dFOXO may affect when
its expression is increased to attenuate cardiac dysfunction with age. We will
systematically investigate these candidates to pinpoint howmild FOXO overex-
pression ameliorates the natural decline in heart performance in Drosophila.
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The intercalated disc (ID) of cardiac muscle embodies a highly ordered, multi-
functional network, which is essential for the transmission of electrical stimuli
and mechanical force resulting in the synchronous contraction of the heart.
Recently, a plethora of proteins have been identified as novel components of
the ID. The challenge now lies in their characterization. Here we focus on
the molecular and functional description of two novel members of the ID,
obscurin-80 and obscurin-40.
Obscurins are a family of proteins expressed in striated muscles where they
localize to distinct subdomains. The members of the obscurin family are multi-
domain proteins composed of adhesion modules and signaling domains, result-
ing from extensive alternative splicing of transcripts arising from the single
OBSCN gene. Recent work from our laboratory has demonstrated that complex
splicing at the 3’ end of the obscurin transcript gives rise to at least two novel
obscurins, obscurin-80 (obsc-80) and obscurin-40 (obsc-40), named after their
predicted molecular weights.
Using immunofluorescence and immunoelectron microscopy, we show that
obsc-80 and obsc-40 localize to the ID of developing and adult murine cardio-
myocytes. Using biochemical assays we further demonstrate that both obsc-80
and obsc-40 exist in a complex with major ID proteins, including N-cadherin,
connexin-43, vinculin, and ankyrin-G. The PH domain present in both obsc-80
and obsc-40 binds specifically and directly binds to phosphatidylinositol 3,4
and 4,5 bisphosphates, likely targeting both proteins to the ID membrane. Over-
expression of the obscurin PH domain results in decreased phosphorylation of
Akt, therefore reducing Akt activation. This suggests a potential role for obsc-
80 and obsc-40 in the regulation of cell growth and proliferation via the Akt
pathway. Further experiments are underway to examine the functional activ-
ities of obsc-80 and obsc-40 at the ID and their regulation in health and
disease.1814-Plat
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The troponin complex plays a central role in the allosteric function of sarco-
meric thin filaments by enacting conformational changes during the Ca2þ-regu-
lated contraction and relaxation of striated muscle. The troponin subunit T
(TnT) has two binding sites for tropomyosin (Tm) and is responsible for
anchoring the troponin complex to the thin filament. Although the C-terminal
and middle regions of the TnT polypeptide chain are highly conserved among
the three muscle type isoforms, the hypervariable N-terminal region has evolu-
tionarily diverged significantly among isoforms. Previous studies have shown
that the N-terminal variable region fine-tunes Ca2þ regulation of muscle
contractility via modulation of the overall molecular conformation of TnT,
and its interactions with Tm. In the present study, we engineered intact TnT
and representative fragments of TnT, expressed them in E. coli, and prepared
purified proteins for functional studies. Tropomyosin binding affinity was
analyzed using affinity chromatography and solid phase protein binding assays
to investigate the modulatory effects of the N-terminal variable region. The re-
sults demonstrated that in the absence of the N-terminal variable region, TnT’s
conserved middle region and C-terminal T2 region Tm-binding sites showed
comparable Tm-binding affinities across isoforms. The data demonstrate that
without the modulatory effect of the N-terminal variable region, the intrinsic
Tm-binding affinities of the two sites are both high. In contrast, the presence
of the isoform specific N-terminal variable region differentially reduces the
binding affinity of TnT for Tm, primarily at the middle region binding site.
These novel findings indicate that the N-terminal variable region plays a key
role in the functional difference of muscle fiber type-specific, developmental,
splice variant, and pathogenic TnT isoforms by modulating the interactions
with Tm during the contraction and relaxation of cardiac and skeletal muscle.
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The importance of RLC phosphorylation in enhancing cardiac myofibrillar
contraction is well-known. In anesthetized mice the extent of RLC phosphory-
lation (45%) was not changed by changes in sympathetic tone with prolonged
infusion of the beta-agonist dobutamine or treatment with the beta-blocker pro-
pranolol. The goal of this study was to determine if the constitutive RLC phos-
phorylation in vivo was limited to half of the RLC due to: a) negative
cooperativity for phosphorylation of two heads in myosin; or b) due to a steric
constraint in myofibrils blocking access of soluble cardiac myosin light chain
kinase (cMLCK) to RLC. We measured the kinetic properties of RLC phos-
phorylation in native myosin filaments and myofibrils. Results showed that
RLC was phosphorylated by a pseudo-first order rate in both preparations
with maximal phosphorylation over 90%. Thus, RLC for each head in myosin
was readily available for phosphorylation. Pacing trabeculae at 1.5 Hz for 30
minutes increased RLC phosphorylation from 2051 % to 4353 %. Consistent
with biochemical results, RLC phosphorylation increased to 9153 % when
myosin light chain phosphatase activity was inhibited with calyculin A while
pacing. Together, these results exclude negative cooperativity and steric block-
ing as mechanisms limiting RLC phosphorylation. We determined that the
heart has a high cMLCK content (2.450.1 mM) compared to the MLCK pre-
sent in fast skeletal muscle (0.550.03 mM), but similar to the MLCK content
in smooth muscle (3.450.2 mM). However cMLCK has a low specific activity
compared to the other MLCKs. In conclusion, the extent of RLC phosphoryla-
tion in a normally beating heart is limited by cMLCK with its low activity in
balance with low myosin light chain phosphatase activity. RLC phosphoryla-
tion is insensitive to sympathetic activation or inhibition in vivo.
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Sensitivity by Troponin I Phosphorylation Caused by Hypertrophic and
Dilated Cardiomyopathy Mutations in Cardiac Muscle
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Heart muscle contraction is regulated via the b-adrenergic response that leads
to phosphorylation of Troponin I (TnI) at Ser 22/23, which changes the Ca2þ-
sensitivity of the cardiac myofilament. Previously it has been shown that mu-
tations found in Dilated Cardiomyopathy (DCM) and Hypertrophic
362a Tuesday, February 10, 2015Cardiomyopathy (HCM) patients abolish the relationship between TnI phos-
phorylation and Ca2þ-sensitivity (uncoupling).
Ca2þ-sensitisers and Ca2þ-desensitisers that act upon troponin alter the Ca2þ-
sensitivity of the myofilament but their relationship with TnI phosphorylation
has never been studied before.
Epigallocatechin-3-gallate (EGCG) is a major extract of green tea and it also
acts as a Ca2þ-desensitiser by binding to Troponin C of the myofilament.
100 mM EGCG decreased Ca2þ-sensitivity of phosphorylated and unphos-
phorylated wild-type thin filaments equally (by 2.1550.45 and 2.8050.48-
fold respectively), retaining the coupling. In contrast, EGCG reduced
Ca2þ-sensitivity of phosphorylated but not unnphosphorylated thin filaments
containing 8 DCM (TPM1 E54K and E40K, TNNC1 G159D, TNNI3 K36Q,
ACTC E361G) and HCM (TPM1 E180G, TNNT2 K280N, ACTC E99K)-
causing mutations. As a result the dependence of Ca2þ-sensitivity upon TnI
phosphorylation of uncoupled mutant thin filaments was restored in every
case. In single myofibrils, EGCG reduced Ca2þ-sensitivity of force and kACT
and also preserved the coupling with wild type and restored coupling with
ACTC E361G mutant myofibrils.
The effect of EGCG demonstrates that it is possible to reverse the pathological
defects in troponin caused by HCM mutations pharmacologically.
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Cardiac contraction is initiated by calcium release from the sarcoplasmic retic-
ulum through channels (ryanodine receptors) that are located near the sarco-
mere ends. Once released, calcium must diffuse towards the sarcomere
center to fully activate the actomyosin contractile system. This physical
arrangement should lead to a spatial calcium gradient and thus non-uniform
contractile activation. We hypothesize that myosin-binding protein C
(MyBP-C), a potent thin filament activator, is localized to the sarcomere center
(C-zone) to mitigate the potential deficit in calcium activation. We used EM
and super-resolution STORM microscopy to visualize the relative positions
of the ryanodine receptors and MyBP-C within the sarcomere. Laser scanning
confocal microscopy of calcium transients in isolated cardiac cells showed that
calcium concentrations at the center of each sarcomere lagged those near the
ends of each sarcomere by as much as 150 nM. The functional impact of this
calcium gradient was determined by examining the sliding of native,
calcium-sensitive actin-thin filament shards over native mouse cardiac
myosin-thick filaments using a TIRFM-based motility assay. The presence of
MyBP-C enhanced the fraction of thin filaments moving within the thick fila-
ment C-zone (pCa50 6.55 0.04 vs 6.45 0.02; p<0.01). 3D EM reconstruc-
tions of native thin filaments suggest this calcium sensitization results from
MyBP-C’s N-terminal domains shifting tropomyosin on the thin filament. Us-
ing an analytic model, we show that MyBP-C residing within the C-zone can
counterbalance differences in calcium activation within the sarcomere during
the early phase of contraction. Thus, MyBP-C’s localization to the C-zone
may function to correct an intrinsic defect in cardiac excitation-contraction
coupling, and any disturbance of MyBP-C localization or function will
contribute to the consequent cardiac pathologies.
1818-Plat
Direct Detection of the Thermodynamics and Structural Kinetics of a
2-Color SERCA Biosensor by Transient Time-Resolved FRET
Simon J. Gruber1, Rebecca Goldblum2, Jenica Zhong2, Kurt Peterson2,
Tory M. Schaaf2, Joseph M. Autry2, Gregory D. Gillispie2,
David D. Thomas2, Joseph M. Muretta2.
1Mount Sinai Hospital, New York, NY, USA, 2Department of Biochemistry,
Molecular Biology and Biophysics, University of Minnesota, Minneapolis,
MN, USA.
We are investigating the structural dynamics of the calcium pump SERCA, us-
ing a 2-color biosensor and time-resolved FRETmeasurements. SERCAcouples
ATP hydrolysis to Ca2þ transport across the sarcoplasmic or endoplasmic retic-
ulum membrane. Crystal structures suggest that SERCA structure changes
dramatically during active Ca2þ transport, including large movements in thecytoplasmic N andA domains, coupled to more subtle changes in the transmem-
brane domain. However, there is little direct evidence showing how changes in
SERCA structure coordinate, in solution and in cells, with individual steps in the
pump’s ATPase and Ca2þ transport cycles. Furthermore, SERCA is a viable
therapeutic target for a host of diseases_heart failure, diabetes, and cancer_so
it is important to understand how the ATPase and Ca2þ transport cycles are
coupled to changes in the protein’s structure. We are addressing these questions
using a recombinant 2-color SERCAbiosensor (RFP andGFP fused to theN and
A domains) developed byRobia and coworkers for live-cell work. Herewe use it
in isolated membrane fragments to detect changes in SERCA structure in
response to changes in Ca2þ and nucleotide concentrations, both at equilibrium
and in the transient phase after rapid mixing. Our results: 1) reveal critical
changes in the structural-dynamics of the SERCA cytoplasmic domains upon
Ca2þ and nucleotide binding; and 2) suggest a structural-kinetic mechanism
for Ca2þ activation of ATPase cycling with coordinated changes in the position
of the cytoplasmic domains in association with sequential binding of Ca2þ ions
and ATP. 3) These results also allow direct testing of x-ray crystal structure
models in solution and in living cells and inform the discovery of novel SERCA
modulators that directly target the pump’s structural dynamics.
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Normal cardiac contraction and relaxation requires efficient operation of the SR
Ca2þ ATPase, SERCA2a. In failing hearts, decreased SERCA2a expression
and slowed SR Ca2þ reuptake are thought to significantly underlie contractile
dysfunction. We have studied the relationship between decreased SERCA2a
expression and cardiac function using a mouse model of conditional cardiac
Serca2 ablation, the Serca2fl/fl mouse. In this model, Cre activation by tamox-
ifen injection efficiently deletes Serca2 from the heart; four weeks post-
knockout, cardiac SERCA2a protein content is below 5% of normal levels.
Serca2 KO mice survive 7-10 weeks post knockout with only mild in vivo
impairment prior to this time, suggesting that this loss of SERCA2a protein
can be temporarily compensated. We found that isolated SERCA2a KO hearts
retained the ability to respond to ß-adrenergic stimulation ex vivo despite the
loss of most SERCA2a protein. Because the protein regulator of SERCA2a,
phospholamban (PLN), is thought to be a major component of the cardiac ß-
adrenergic response, this finding was unexpected and warranted further detailed
investigation. To identify the mechanism underlying this preserved ß-adren-
ergic response in SERCA2-depleted hearts, we bred Serca2fl/fl and PLN-/-
mice to generate an inducible Serca2 knockout mouse line lacking PLN.
Serca2fl/fl;PLN-/- mice were injected with tamoxifen to induce Serca2 gene
disruption, and isolated hearts from Serca2KO;PLN-/- (‘‘DKO’’) mice were
evaluated by Langendorff perfusion 4-5 weeks after Serca2 knockout. Control
PLN-/- hearts show little response to ß-adrenergic stimulation, and DKO hearts
have impaired contractility under baseline conditions. DKO hearts, however,
show improved systolic and diastolic function when perfused with 50 nM
isoproterenol, indicating that targets of ß-adrenergic signaling beyond PLN
are able to support a significant inotropic and lusitropic response when cardiac
contractility is impaired.We will discuss how these findings support newmech-
anisms underlying heart performance during stress and disease.
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The HIV-1 envelope (Env) mediates viral entry into host cells. While static im-
ages of Env in unliganded and ligand-bound forms define distinct
